Moxiflox-Infuzia solution for infusions 400 mg/250 ml. 250 ml. vial

Description

Moxiflox composition
The drug contains the active ingredient: moxifloxacin 1.6 mg in 1 ml of solution, as well as additional substances: sodium hydroxide, sodium chloride, water for injection and hydrochloric acid.

Release form
The drug is produced in the form of a clear yellow solution for infusion.
A cardboard box contains one bottle of 250 ml (400 mg of moxifloxacin) solution.

Pharmacological properties
Moxiflox is an antimicrobial drug that belongs to fluoroquinolone antibiotics. The drug is active against anaerobic, atypical, gram-negative and gram-positive bacteria. It has a bactericidal effect, the action of which disrupts the synthesis of DNA of microorganisms, which ultimately leads to their death. The drug is well tolerated and safe, it is used for many infectious diseases, providing a rapid regression of symptoms.

Indications
Moxiflox is used to treat infectious bacterial diseases caused by microorganisms that are sensitive to the drug:

• community-acquired pneumonia;
• acute sinusitis;
• chronic bronchitis in the acute stage;
• prostatitis, pyelonephritis, ureaplasmosis;
• complicated intra-abdominal infections;
• chlamydia;
• mycoplasmosis;
• infectious diseases of soft tissues or skin.

Contraindications
The drug has practically no contraindications, with the exception of hypersensitivity to the constituent substances and childhood. Also, the drug should not be administered simultaneously with 10% or 20% sodium chloride solution and 4.2% or 8.4% sodium bicarbonate solution.

Application during pregnancy and lactation
The drug is contraindicated for use during pregnancy and lactation.

Method of administration and dosage
The recommended daily dose of Moxiflox is 400 mg for any infections indicated in the indications for use.
The duration of therapy depends on the severity of the disease itself and the clinical picture:

• acute sinusitis – duration of treatment 1 week;
• community-acquired pneumonia – 10 days;
• exacerbation of chronic bronchitis – 5 days;
• prostatitis – 20-30 days;
• infectious processes of the skin and soft tissues – 1 week;
• pyelonephritis – 1-2 weeks;
• complicated intra-abdominal infections – 5-14 days;
• urogenital infections – 10 days.

It is not recommended to exceed the recommended doses and duration of therapy.

Overdose
In case of an overdose of the drug, aggravation of side effects may occur. In this case, it is necessary to rinse the stomach, stop taking the drug, take sorbents and carry out symptomatic treatment.

Side effects
The administration of the drug very often causes such side effects as: nervousness, anxiety, dizziness, headache, depression, weakness, apathy, insomnia, palpitations, confusion, chest pain, convulsions, tremors, leg pain and paresthesia.
You may also experience: tachycardia, nausea, hypertension, diarrhea, abdominal pain, flatulence, vomiting, constipation, changes in taste, a temporary increase in liver enzyme activity, a decrease in the level of leukocytes, an increase in the level of eosinophils and platelets, anemia, joint pain, vaginal candidiasis , peripheral edema, muscle and back pain.
Possible manifestations of allergic reactions, such as rash, hives and itching.

Storage conditions and periods
Moxiflox should be stored in its original packaging, at a temperature not exceeding + 25 ° C, the storage place should not be accessible to children. The drug must not be frozen.
Expiration date 24 months.